Postoperative pneumonia following cardiac surgery in non-ventilated patients versus mechanically ventilated patients: Is there any difference?

Critical Care

Volumn 19, Issue 1, 2015, Pages

  Allou, Nicolas ^a,b   Allyn, Jerome ^a,b   Snauwaert, Aurélie ^b,c   Welsch, Camille ^b,c   Lucet, Jean Christophe ^b   Kortbaoui, Rita ^b,c   Desmard, Mathieu ^b,c   Augustin, Pascal ^b,c   Montravers, Philippe ^b,c  

^a Hôpital Universitaire Félix Guyon Réanimation Polyvalente Allée des Topazes   (France)

^b BICHAT HOSPITAL   (France)

^c UNIVERSITÉ PARIS DESCARTES   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; CEFAMANDOLE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; IMIPENEM; PIPERACILLIN PLUS TAZOBACTAM; ANTIINFECTIVE AGENT; PIPERACILLIN;

AGED; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; ARTIFICIAL VENTILATION; BRONCHOSCOPY; CARDIAC PATIENT; CARDIOPULMONARY BYPASS; COHORT ANALYSIS; CONGESTIVE HEART FAILURE; DIABETES MELLITUS; ENTEROBACTERIACEAE; FEMALE; HAEMOPHILUS; HEART SURGERY; HUMAN; INTENSIVE CARE UNIT; LENGTH OF STAY; LUNG LAVAGE; MAJOR CLINICAL STUDY; MALE; MEDICAL HISTORY; METHICILLIN SUSCEPTIBLE STAPHYLOCOCCUS AUREUS; MONOTHERAPY; OPERATION DURATION; PNEUMONIA; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PSEUDOMONAS AERUGINOSA; RETROSPECTIVE STUDY; RISK FACTOR; SEQUENTIAL ORGAN FAILURE ASSESSMENT SCORE; SURVIVOR; VENTILATED PATIENT; ADVERSE EFFECTS; COMPARATIVE STUDY; CRITICAL ILLNESS; GRAM NEGATIVE BACTERIUM; HOSPITAL MORTALITY; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MIDDLE AGED; PNEUMONIA, VENTILATOR-ASSOCIATED; POSTOPERATIVE COMPLICATIONS; SEVERITY OF ILLNESS INDEX; VERY ELDERLY;

AGED; AGED, 80 AND OVER; ANTI-BACTERIAL AGENTS; CARDIAC SURGICAL PROCEDURES; CRITICAL ILLNESS; FEMALE; GRAM-NEGATIVE BACTERIA; HOSPITAL MORTALITY; HUMANS; INCIDENCE; INTENSIVE CARE UNITS; MALE; MIDDLE AGED; PIPERACILLIN; PNEUMONIA; PNEUMONIA, VENTILATOR-ASSOCIATED; POSTOPERATIVE COMPLICATIONS; RESPIRATION, ARTIFICIAL; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX;

EID: 84925297525     PISSN: 13648535     EISSN: 1466609X     Source Type: Journal    
DOI: 10.1186/s13054-015-0845-5     Document Type: Article

References (22)

1. Kollef MH, Sharpless L, Vlasnik J, Pasque C, Murphy D, Fraser VJ. The impact of nosocomial infections on patient outcomes following cardiac surgery. Chest. 1997;112:666-75.
2. Hortal J, Munoz P, Cuerpo G, Litvan H, Rosseel PM, Bouza E. Ventilator-associated pneumonia in patients undergoing major heart surgery: an incidence study in Europe. Crit Care. 2009;13:R80.
3. Hortal J, Giannella M, Perez MJ, Barrio JM, Desco M, Bouza E, et al. Incidence and risk factors for ventilator-associated pneumonia after major heart surgery. Intensive Care Med. 2009;35:1518-25.
4. Leal-Noval SR, Marquez-Vacaro JA, Garcia-Curiel A, Camacho-Larana P, Rincon-Ferrari MD, Ordonez-Fernandez A, et al. Nosocomial pneumonia in patients undergoing heart surgery. Crit Care Med. 2000;28:935-40.
5. Montravers P, Veber B, Auboyer C, Dupont H, Gauzit R, Korinek AM, et al. Diagnostic and therapeutic management of nosocomial pneumonia in surgical patients: results of the Eole study. Crit Care Med. 2002;30:368-75.
6. Allou N, Bronchard R, Guglielminotti J, Dilly MP, Provenchere S, Lucet JC, et al. Risk factors for postoperative pneumonia after cardiac surgery and development of a preoperative risk score*. Crit Care Med. 2014;42:1150-6.
7. Device-associated Events Module, Ventilator-Associated Pneumonia (VAP) Event. Centers for Disease Control and Prevention (CDC) and National Healthcare Safety Network (NHSN) Report, 2013;6:1-13
8. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med. 2005;171:388-416.
9. Antibiogram Committee of the French Society for Microbiology. CASFM: http://www.sfm-microbiologie.org/.
10. Bouza E, Hortal J, Munoz P, Pascau J, Perez MJ, Hiesmayr M. Postoperative infections after major heart surgery and prevention of ventilator-associated pneumonia: a one-day European prevalence study (ESGNI-008). J Hosp Infect. 2006;64:224-30.
11. Allou N, Kermarrec N, Muller C, Thabut G, Philip I, Lucet JC, et al. Risk factors and prognosis of post-operative pneumonia due to Pseudomonas aeruginosa following cardiac surgery. J Antimicrob Chemother. 2010;65:806-7.
12. Esperatti M, Ferrer M, Theessen A, Liapikou A, Valencia M, Saucedo LM, et al. Nosocomial pneumonia in the intensive care unit acquired by mechanically ventilated versus nonventilated patients. Am J Respir Crit Care Med. 2010;182:1533-9.
13. Kohlenberg A, Schwab F, Behnke M, Geffers C, Gastmeier P. Pneumonia associated with invasive and noninvasive ventilation: an analysis of the German nosocomial infection surveillance system database. Intensive Care Med. 2010;36:971-8.
14. Rello J, Ulldemolins M, Lisboa T, Koulenti D, Manez R, Martin-Loeches I, et al. Determinants of prescription and choice of empirical therapy for hospital-acquired and ventilator-associated pneumonia. Eur Respir J. 2011;37:1332-9.
15. Weber DJ, Rutala WA, Sickbert-Bennett EE, Samsa GP, Brown V, Niederman MS. Microbiology of ventilator-associated pneumonia compared with that of hospital-acquired pneumonia. Infect Control Hosp Epidemiol. 2007;28:825-31.
16. Rello J, Ausina V, Ricart M, Puzo C, Quintana E, Net A, et al. Risk factors for infection by Pseudomonas aeruginosa in patients with ventilator-associated pneumonia. Intensive Care Med. 1994;20:193-8.
17. Trouillet JL, Chastre J, Vuagnat A, Joly-Guillou ML, Combaux D, Dombret MC, et al. Ventilator-associated pneumonia caused by potentially drug-resistant bacteria. Am J Respir Crit Care Med. 1998;157:531-9.
18. Verhamme KM, De Coster W, De Roo L, De Beenhouwer H, Nollet G, Verbeke J, et al. Pathogens in early-onset and late-onset intensive care unit-acquired pneumonia. Infect Control Hosp Epidemiol. 2007;28:389-97.
19. Kollef KE, Schramm GE, Wills AR, Reichley RM, Micek ST, Kollef MH. Predictors of 30-day mortality and hospital costs in patients with ventilator-associated pneumonia attributed to potentially antibiotic-resistant gram-negative bacteria. Chest. 2008;134:281-7.
20. Kumar A, Roberts D, Wood KE, Light B, Parrillo JE, Sharma S, et al. Duration of hypotension before initiation of effective antimicrobial therapy is the critical determinant of survival in human septic shock. Crit Care Med. 2006;34:1589-96.
21. Fagon JY, Chastre J, Hance AJ, Domart Y, Trouillet JL, Gibert C. Evaluation of clinical judgment in the identification and treatment of nosocomial pneumonia in ventilated patients. Chest. 1993;103:547-353.
22. Singh N, Falestiny MN, Rogers P, Reed MJ, Pularski J, Norris R, et al. Pulmonary infiltrates in the surgical ICU: prospective assessment of predictors of etiology and mortality. Chest. 1998;114:1129-36.